EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma

Kiyasha Padarath, Aurélie Deroubaix, Anna Kramvis iD

Viruses · 27.03.2023 · 15 (4) · 857

DOI: 10.3390/v15040857 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 27.03.2023. Verfasst von Kiyasha Padarath und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hepatitis Virus Diversity Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Association of South Africa, National Research Foundation (NRF), Poliomyelitis Research Foundation (PRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) is one of the seven known human oncogenic viruses and has adapted to coexist with a single host for prolonged periods, requiring continuous manipulation of immunity and cell fate decisions. The persistence of HBV infection is associated with the pathogenesis of hepatocellular carcinoma, and various HBV proteins have been implicated in promoting this persistence. The precursor of hepatitis e antigen (HBeAg), is translated from the precore/core region and is post-translationally modified to yield HBeAg, which is secreted in the serum. HBeAg is a non-particulate protein of HBV and can act as both a tolerogen and an immunogen. HBeAg can protect hepatocytes from apoptosis by interfering with host signalling pathways and acting as a decoy to the immune response. By evading the immune response and interfering with apoptosis, HBeAg has the potential to contribute to the hepatocarcinogenic potential of HBV. In particular, this review summarises the various signalling pathways through which HBeAg and its precursors can promote hepatocarcinogenesis via the various hallmarks of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis BHepatitis B, ChronicHumansHepatitis B e AntigensHepatitis B virusMutationDNA, Viral

Stichwörter der Autor:innen

HBeAghepatitis B virushepatocellular carcinoma

Substanzen

Hepatitis B e AntigensDNA, Viral

Autor:innen und Institutionen

  • Hepatitis Virus Diversity Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg 2193, South Africa.
  • Life Sciences Imaging Facility, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg 2193, South Africa.

ORCID-Profile: Anna Kramvis

Förderung

  • Cancer Association of South Africa
  • National Research Foundation (NRF)
  • Poliomyelitis Research Foundation (PRF)

Zitieren

APA

Padarath, K., Deroubaix, A., & Kramvis, A. (2023). The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma. Viruses, 15(4), 857. https://doi.org/10.3390/v15040857

Vancouver

Padarath K, Deroubaix A, Kramvis A. The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma. Viruses. 2023;15(4):857. doi:10.3390/v15040857

BibTeX
@article{Padarath2023,
  author = {Padarath, Kiyasha and Deroubaix, Aurélie and Kramvis, Anna},
  title = {The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {857},
  doi = {10.3390/v15040857}
}
Kostenlos starten →